Patents by Inventor Min-Ching Chung

Min-Ching Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THIOPURINE-BASED COMPOUND, COMPOSITION, METHOD OF PREPARATION AND APPLICATIONS
    Publication number: 20230226230
    Abstract: A compound for measurement of thiopurine pathway directed systems imaging and therapy including a chelator and a thiopurine ligand is provided. A method of synthesizing the compound is also provided, and the compound may be further prepared in pharmaceutical formulations or kits for therapy or molecular imaging.
    Type: Application
    Filed: February 26, 2021
    Publication date: July 20, 2023
    Applicant: SEECURE TAIWAN CO., LTD.
    Inventors: Wei-Chung CHANG, David J. YANG, Min-Ching CHUNG, Chi-Shiang KE, Tsung-Tien KUO
  • Composition for cross talk between estrogen receptors and cannabinoid receptors
    Patent number: 11090395
    Abstract: A composition for cross talk between estrogen receptors and cannabinoid receptors including a chelator and a receptor ligand is provided. A method of synthesizing the composition is also provided, and the composition may be further prepared in pharmaceutical formulations or kits for therapy or molecular imaging.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: August 17, 2021
    Assignee: SeeCure Taiwan Co., Ltd.
    Inventors: Tsung-Tien Kuo, David J. Yang, Wei-Chung Chang, Min-Ching Chung, Chi-Shiang Ke
  • COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABINOID RECEPTORS
    Publication number: 20210196655
    Abstract: A composition for cross talk between estrogen receptors and cannabinoid receptors including a chelator and a receptor ligand is provided. A method of synthesizing the composition is also provided, and the composition may be further prepared in pharmaceutical formulations or kits for therapy or molecular imaging.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 1, 2021
    Applicant: SeeCure Taiwan Co., Ltd.
    Inventors: Tsung-Tien Kuo, David J. Yang, Wei-Chung Chang, Min-Ching Chung, Chi-Shiang Ke
  • COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABIONOID RECEPTORS
    Publication number: 20200085978
    Abstract: A composition for cross talk between estrogen receptors and cannabinoid receptors including a chelator and a receptor ligand is provided. A method of synthesizing the composition is also provided, and the composition may be further prepared in pharmaceutical formulations or kits for therapy or molecular imaging.
    Type: Application
    Filed: September 14, 2018
    Publication date: March 19, 2020
    Applicant: SeeCure Taiwan Co., Ltd.
    Inventors: Tsung-Tien Kuo, David J. Yang, Wei-Chung Chang, Min-Ching Chung, Chi-Shiang Ke